首页 > 最新文献

SAGE Open Medicine最新文献

英文 中文
Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review. 射频识别技术;一种分析伪造药品的方法:文献综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241272725
Minichil Chanie Worku, Melaku Getahun Feleke, Tewodros Denekew, Yeniewa Kerie Anagaw

Quality has been a concern of the World Health Organization since its inception and is defined as fitness for use. Since our ancestors began trading several millennia ago, Falsified Pharmaceutical Products has been a recurring problem and still threatens economic stability and public health. Its definition various from country to country and according to World Health Organization, 2017, it is 'a product that is deliberately and fraudulently mislabelled with respect to identity and/or source'. The implementation of anti-falsified nanomaterial technologies is the prominent preventive measure to track and/or detect Falsified Pharmaceutical Products. Software and hardware companies had made encouraging progress towards implementing Radio Frequency Identification devices for ensuring the authenticity of pharmaceutical products. The purpose of the review was to critically appraise Radio Frequency Identification devices technology for the purpose of track and trace Falsified Pharmaceutical Products circulating in the market. Different search engines such as Google Scholar, Science Direct and PubMed were applied and mesh terms and keywords were searched. Different guides and related books were investigated in addition to the articles. Radio Frequency Identification devices technology is a compact electronic device that contains a small chip and reader with antenna that enables wireless transmission of identity of pharmaceutical products. The authenticated Radio Frequency Identification devices model is used for pharmaceutical products' authentication from origin of pharmaceutical industry to the pharmacy at any point along the chain of the distribution. Popular pharmaceutical products, such as OxyContin and Sildenafil Citrate, which are particular targets of falsification have mandated the use of Radio Frequency Identification devices technology.

自世界卫生组织成立以来,质量一直是其关注的问题,质量的定义是适合使用。自几千年前我们的祖先开始从事贸易以来,掺假药品一直是一个反复出现的问题,至今仍威胁着经济稳定和公众健康。各国对它的定义不尽相同,根据世界卫生组织 2017 年的定义,它是 "一种在身份和/或来源方面故意和欺诈性地贴错标签的产品"。采用反掺假纳米材料技术是追踪和/或检测掺假医药产品的主要预防措施。软件和硬件公司在采用射频识别装置确保药品真实性方面取得了令人鼓舞的进展。本综述旨在对射频识别设备技术进行严格评估,以跟踪和追查市场上流通的假药。我们使用了不同的搜索引擎,如 Google Scholar、Science Direct 和 PubMed,并搜索了网格术语和关键词。除文章外,还调查了不同的指南和相关书籍。射频识别设备技术是一种紧凑型电子设备,包含一个小型芯片和带有天线的读取器,可以无线传输药品的身份信息。经认证的射频识别设备模型可用于医药产品从制药业原产地到药房销售链条上任何一个环节的认证。奥施康定(OxyContin)和枸橼酸西地那非(Sildenafil Citrate)等热门药品是特别容易被伪造的目标,因此已强制要求使用射频识别设备技术。
{"title":"Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review.","authors":"Minichil Chanie Worku, Melaku Getahun Feleke, Tewodros Denekew, Yeniewa Kerie Anagaw","doi":"10.1177/20503121241272725","DOIUrl":"10.1177/20503121241272725","url":null,"abstract":"<p><p>Quality has been a concern of the World Health Organization since its inception and is defined as fitness for use. Since our ancestors began trading several millennia ago, Falsified Pharmaceutical Products has been a recurring problem and still threatens economic stability and public health. Its definition various from country to country and according to World Health Organization, 2017, it is 'a product that is deliberately and fraudulently mislabelled with respect to identity and/or source'. The implementation of anti-falsified nanomaterial technologies is the prominent preventive measure to track and/or detect Falsified Pharmaceutical Products. Software and hardware companies had made encouraging progress towards implementing Radio Frequency Identification devices for ensuring the authenticity of pharmaceutical products. The purpose of the review was to critically appraise Radio Frequency Identification devices technology for the purpose of track and trace Falsified Pharmaceutical Products circulating in the market. Different search engines such as Google Scholar, Science Direct and PubMed were applied and mesh terms and keywords were searched. Different guides and related books were investigated in addition to the articles. Radio Frequency Identification devices technology is a compact electronic device that contains a small chip and reader with antenna that enables wireless transmission of identity of pharmaceutical products. The authenticated Radio Frequency Identification devices model is used for pharmaceutical products' authentication from origin of pharmaceutical industry to the pharmacy at any point along the chain of the distribution. Popular pharmaceutical products, such as OxyContin and Sildenafil Citrate, which are particular targets of falsification have mandated the use of Radio Frequency Identification devices technology.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241272725"},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19. COVID 19 大流行对神经内科住院治疗的影响,分析继发于 COVID 19 和接种 COVID 19 疫苗的神经系统并发症。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-28 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241272518
Kosuke Matsuzono, Makiko Mieno, Takafumi Mashiko, Yuhei Anan, Tadashi Ozawa, Reiji Koide, Ryota Tanaka, Akio Kimura, Shigeru Fujimoto

Objective: We investigated the effect of the pandemic on neurological hospitalizations and complications associated with severe acute respiratory syndrome coronavirus 2 infection or vaccinations.

Methods: We retrospectively analyzed data of patients hospitalized in our neurology division from 1 April 2019 to 31 March 2022 as the opt-out study. We classified the neurological diseases into nine subgroups, evaluated changes of neurological disease characteristics, and analyzed patients hospitalized with the complications from severe acute respiratory syndrome coronavirus 2 infection or after the coronavirus disease 2019 vaccination over three eras based on the pandemic stages: (1) pre-pandemic, (2) during the pandemic but before vaccines, and (3) during the pandemic with vaccines.

Results: Overall, 1756 patients were included in the analyses. The patient characteristics significantly changed throughout the pandemic (p < 0.01). Although the number of autoimmune cases did not change throughout the pandemic (p = 0.53), that of psychological cases and that of unknown cases were significantly changed (p < 0.05, p < 0.01). There were four infectious cases and 11 cases following vaccination from 1 April 2020 to 31 March 2022. The 11 postvaccination cases involved 10 kinds of neurological diseases.

Conclusions: The neurological characteristics significantly changed throughout the pandemic and there were diverse neurological complications following vaccinations.

目的我们调查了大流行对神经科住院患者的影响以及与严重急性呼吸系统综合征冠状病毒 2 感染或疫苗接种相关的并发症:我们回顾性分析了2019年4月1日至2022年3月31日在我院神经内科住院的患者数据,作为选择退出研究。我们将神经系统疾病分为九个亚组,评估了神经系统疾病特征的变化,并根据大流行阶段分析了三个时期因严重急性呼吸系统综合征冠状病毒 2 感染并发症或接种冠状病毒病 2019 年疫苗后住院的患者:(1) 大流行前;(2) 大流行期间但疫苗接种前;(3) 大流行期间接种疫苗后:共有 1756 名患者参与了分析。在整个大流行期间,患者的特征发生了明显变化(P P = 0.53),心理病例和未知病例的特征发生了明显变化(P P 结论):在整个大流行期间,神经系统特征发生了明显变化,接种疫苗后出现了多种神经系统并发症。
{"title":"Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19.","authors":"Kosuke Matsuzono, Makiko Mieno, Takafumi Mashiko, Yuhei Anan, Tadashi Ozawa, Reiji Koide, Ryota Tanaka, Akio Kimura, Shigeru Fujimoto","doi":"10.1177/20503121241272518","DOIUrl":"10.1177/20503121241272518","url":null,"abstract":"<p><strong>Objective: </strong>We investigated the effect of the pandemic on neurological hospitalizations and complications associated with severe acute respiratory syndrome coronavirus 2 infection or vaccinations.</p><p><strong>Methods: </strong>We retrospectively analyzed data of patients hospitalized in our neurology division from 1 April 2019 to 31 March 2022 as the opt-out study. We classified the neurological diseases into nine subgroups, evaluated changes of neurological disease characteristics, and analyzed patients hospitalized with the complications from severe acute respiratory syndrome coronavirus 2 infection or after the coronavirus disease 2019 vaccination over three eras based on the pandemic stages: (1) pre-pandemic, (2) during the pandemic but before vaccines, and (3) during the pandemic with vaccines.</p><p><strong>Results: </strong>Overall, 1756 patients were included in the analyses. The patient characteristics significantly changed throughout the pandemic (<i>p</i> < 0.01). Although the number of autoimmune cases did not change throughout the pandemic (<i>p</i> = 0.53), that of psychological cases and that of unknown cases were significantly changed (<i>p</i> < 0.05, <i>p</i> < 0.01). There were four infectious cases and 11 cases following vaccination from 1 April 2020 to 31 March 2022. The 11 postvaccination cases involved 10 kinds of neurological diseases.</p><p><strong>Conclusions: </strong>The neurological characteristics significantly changed throughout the pandemic and there were diverse neurological complications following vaccinations.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241272518"},"PeriodicalIF":2.3,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Older Veterans' perspectives on participation in a clinical exercise program: A qualitative study of the VA Gerofit exercise program. 老年退伍军人对参与临床锻炼计划的看法:对退伍军人协会 Gerofit 运动项目的定性研究。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241271759
Lauren M Abbate, Sarah R Jordan, P Michael Ho, Daniel D Matlock, Kelli D Allen, Sarah Wherry, Toby Wellington, Zach J Buxo, Vanessa Richardson, Courtney McGuire, Megan Pearson, Katherine S Hall, Kathryn A Nearing

Objectives: We explored the perspectives of older veterans in Gerofit, a Department of Veteran Affairs (VA) supervised clinical exercise program, to understand the factors associated with participation and how the program supported personal health goals.

Methods: Twenty semistructured interviews were conducted with active and inactive Gerofit participants. We used a hybrid inductive and deductive approach to thematic analysis of transcripts, with the latter informed by the Health Action Process Approach model of behavior change.

Results: Active and inactive participants differed in their perspectives about how Gerofit impacted their progress toward meeting personal health goals. Active participants noted program features (e.g., schedule, staffing) as facilitators and suggested greater self-efficacy about program participation compared to inactive participants. Both groups perceived the camaraderie with other veterans as a facilitator.

Conclusions: Exercise program features, including camaraderie, are important factors that affect the ability of older veterans to participate in exercise and achieve personal health goals.

目标:Gerofit是退伍军人事务部(VA)监督的一项临床锻炼计划,我们探讨了参加该计划的老年退伍军人的观点,以了解参与该计划的相关因素以及该计划如何支持个人健康目标:我们对 Gerofit 的积极参与者和非积极参与者进行了 20 次半结构式访谈。我们采用归纳和演绎混合法对记录誊本进行了主题分析,后者参考了行为改变的健康行动过程方法模型:积极参与者和非积极参与者对 Gerofit 如何影响他们实现个人健康目标的看法有所不同。积极参与者认为项目的特点(如时间安排、人员配备)是促进因素,并表示与非积极参与者相比,他们对参与项目有更强的自我效能感。两组参与者都认为与其他退伍军人的友情是一种促进因素:包括友情在内的运动项目特点是影响老年退伍军人参与运动和实现个人健康目标的重要因素。
{"title":"Older Veterans' perspectives on participation in a clinical exercise program: A qualitative study of the VA Gerofit exercise program.","authors":"Lauren M Abbate, Sarah R Jordan, P Michael Ho, Daniel D Matlock, Kelli D Allen, Sarah Wherry, Toby Wellington, Zach J Buxo, Vanessa Richardson, Courtney McGuire, Megan Pearson, Katherine S Hall, Kathryn A Nearing","doi":"10.1177/20503121241271759","DOIUrl":"https://doi.org/10.1177/20503121241271759","url":null,"abstract":"<p><strong>Objectives: </strong>We explored the perspectives of older veterans in Gerofit, a Department of Veteran Affairs (VA) supervised clinical exercise program, to understand the factors associated with participation and how the program supported personal health goals.</p><p><strong>Methods: </strong>Twenty semistructured interviews were conducted with active and inactive Gerofit participants. We used a hybrid inductive and deductive approach to thematic analysis of transcripts, with the latter informed by the Health Action Process Approach model of behavior change.</p><p><strong>Results: </strong>Active and inactive participants differed in their perspectives about how Gerofit impacted their progress toward meeting personal health goals. Active participants noted program features (e.g., schedule, staffing) as facilitators and suggested greater self-efficacy about program participation compared to inactive participants. Both groups perceived the camaraderie with other veterans as a facilitator.</p><p><strong>Conclusions: </strong>Exercise program features, including camaraderie, are important factors that affect the ability of older veterans to participate in exercise and achieve personal health goals.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241271759"},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence and machine learning a new frontier in the diagnosis of ocular adnexal tumors: A review. 人工智能和机器学习是眼部附件肿瘤诊断的新领域:综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241274197
Qirat Qurban, Lorraine Cassidy

In our article, we explore the transformative potential of Artificial Intelligence and Machine Learning in oculo-oncology, focusing on the diagnosis and management of ocular adnexal tumors. Delving into the intricacies of adnexal conditions such as conjunctival melanoma and squamous conjunctival carcinoma, the study emphasizes recent breakthroughs, such as Artificial Intelligence-driven early detection methods. While acknowledging challenges like the scarcity of specialized datasets and issues in standardizing image capture, the research underscores encouraging patient acceptance, as demonstrated in melanoma diagnosis studies. The abstract calls for overcoming obstacles, conducting clinical trials, establishing global regulatory norms and fostering collaboration between ophthalmologists and Artificial Intelligence experts. Overall, the article envisions Artificial Intelligence's imminent transformative impact on ocular and periocular cancer diagnosis.

在我们的文章中,我们探讨了人工智能和机器学习在眼部肿瘤学中的变革潜力,重点关注眼部附件肿瘤的诊断和管理。该研究深入探讨了结膜黑色素瘤和鳞状结膜癌等附件疾病的复杂性,强调了最近取得的突破,如人工智能驱动的早期检测方法。该研究承认存在专业数据集稀缺和图像采集标准化问题等挑战,但强调患者接受度令人鼓舞,黑色素瘤诊断研究就证明了这一点。摘要呼吁克服障碍,开展临床试验,建立全球监管规范,促进眼科医生和人工智能专家之间的合作。总之,文章展望了人工智能即将对眼部和眼周癌症诊断产生的变革性影响。
{"title":"Artificial intelligence and machine learning a new frontier in the diagnosis of ocular adnexal tumors: A review.","authors":"Qirat Qurban, Lorraine Cassidy","doi":"10.1177/20503121241274197","DOIUrl":"https://doi.org/10.1177/20503121241274197","url":null,"abstract":"<p><p>In our article, we explore the transformative potential of Artificial Intelligence and Machine Learning in oculo-oncology, focusing on the diagnosis and management of ocular adnexal tumors. Delving into the intricacies of adnexal conditions such as conjunctival melanoma and squamous conjunctival carcinoma, the study emphasizes recent breakthroughs, such as Artificial Intelligence-driven early detection methods. While acknowledging challenges like the scarcity of specialized datasets and issues in standardizing image capture, the research underscores encouraging patient acceptance, as demonstrated in melanoma diagnosis studies. The abstract calls for overcoming obstacles, conducting clinical trials, establishing global regulatory norms and fostering collaboration between ophthalmologists and Artificial Intelligence experts. Overall, the article envisions Artificial Intelligence's imminent transformative impact on ocular and periocular cancer diagnosis.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241274197"},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the hospital pharmacy quality assurance system in selected hospitals in the Amhara Regional State, Ethiopia. 埃塞俄比亚阿姆哈拉地区部分医院的医院药房质量保证系统评估。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241272738
Yeniewa Kerie Anagaw, Melaku Getahun Feleke, Endalew Temesgen Mekuriaw, Melese Legesse Mitku, Liknew Workie Limenh, Zemenu Wube Bayleyegn, Minichil Chanie Worku, Tewodros Denekew, Derso Teju Geremew, Wondm Ayenew

Introduction: Pharmacy services in hospitals are designed to meet the needs of all patients. This is undoubtedly one of the most complex services provided by hospitals. In government hospitals, including those in Ethiopia, pharmacies mainly serve as drug stores and dispensaries. To the best of our knowledge, this study is the first to assess and ensure better quality assurance for hospital pharmacy services in Ethiopia. Therefore, the objective of this article was to assess the current status of the quality assurance of pharmacy services in hospitals.

Methods: A cross-sectional survey was conducted. The data were collected from hospital pharmacy heads using the Kobo Collect mobile application and then exported to the Statistical Package for Social Science (SPSS) version 25 for analysis. Descriptive statistics for categorical variables are presented as percentages and frequencies.

Results: All (100%) of the studied hospital pharmacies had a qualified pharmacy director and worked in the pharmacy full-time. Only 40% had a drug information center and a functional drug formulary committee. All pharmacies had their own disposal facilities but did not regularly dispose of expired or unfit medications. The results revealed that all hospital pharmacies did not have a responsible body delegated for quality evaluation.

Conclusion: The findings of this study clearly show that quality assurance services in hospital pharmacies are compromised. The findings can be used to identify areas of improvement and develop strategies to enhance the quality of hospital pharmacy services.

导言:医院的药房服务旨在满足所有病人的需求。这无疑是医院提供的最复杂的服务之一。在包括埃塞俄比亚在内的政府医院中,药房主要充当药库和药房。据我们所知,这项研究是首次对埃塞俄比亚的医院药房服务进行评估,以确保更好的质量保证。因此,本文旨在评估医院药房服务质量保证的现状:方法:进行了一项横向调查。数据是使用 Kobo Collect 移动应用程序从医院药房负责人处收集的,然后导出到社会科学统计软件包 (SPSS) 版本 25 中进行分析。分类变量的描述性统计以百分比和频率表示:所有被研究的医院药房(100%)都有一名合格的药房主任,并在药房全职工作。只有 40% 的药房设有药品信息中心和功能性药品处方委员会。所有药房都有自己的处理设施,但没有定期处理过期或不合格药品。研究结果表明,所有医院药房都没有一个负责质量评估的机构:本研究结果清楚地表明,医院药房的质量保证服务受到了损害。研究结果可用于确定需要改进的领域,并制定提高医院药房服务质量的策略。
{"title":"Assessment of the hospital pharmacy quality assurance system in selected hospitals in the Amhara Regional State, Ethiopia.","authors":"Yeniewa Kerie Anagaw, Melaku Getahun Feleke, Endalew Temesgen Mekuriaw, Melese Legesse Mitku, Liknew Workie Limenh, Zemenu Wube Bayleyegn, Minichil Chanie Worku, Tewodros Denekew, Derso Teju Geremew, Wondm Ayenew","doi":"10.1177/20503121241272738","DOIUrl":"https://doi.org/10.1177/20503121241272738","url":null,"abstract":"<p><strong>Introduction: </strong>Pharmacy services in hospitals are designed to meet the needs of all patients. This is undoubtedly one of the most complex services provided by hospitals. In government hospitals, including those in Ethiopia, pharmacies mainly serve as drug stores and dispensaries. To the best of our knowledge, this study is the first to assess and ensure better quality assurance for hospital pharmacy services in Ethiopia. Therefore, the objective of this article was to assess the current status of the quality assurance of pharmacy services in hospitals.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted. The data were collected from hospital pharmacy heads using the Kobo Collect mobile application and then exported to the Statistical Package for Social Science (SPSS) version 25 for analysis. Descriptive statistics for categorical variables are presented as percentages and frequencies.</p><p><strong>Results: </strong>All (100%) of the studied hospital pharmacies had a qualified pharmacy director and worked in the pharmacy full-time. Only 40% had a drug information center and a functional drug formulary committee. All pharmacies had their own disposal facilities but did not regularly dispose of expired or unfit medications. The results revealed that all hospital pharmacies did not have a responsible body delegated for quality evaluation.</p><p><strong>Conclusion: </strong>The findings of this study clearly show that quality assurance services in hospital pharmacies are compromised. The findings can be used to identify areas of improvement and develop strategies to enhance the quality of hospital pharmacy services.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241272738"},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of isolated very low QRS voltage in tilt-table test for neurally mediated syncope. 倾斜台试验中孤立极低 QRS 电压对神经介导晕厥的预测价值。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241272661
Haichao Chen, Yiwei Cao, Lei Liang, Yan Gao, Jing Feng, Le Zhang, Lingxia Shi, Fengjun Chang, Gong Cheng, Haoyu Wu

Objective: The cause of syncope is generally determined based on clinical manifestations. There has been little discussion about the value of electrocardiograms for diagnosing neurally mediated syncope. The aim of this study was to test the predictive value of the isolated very low QRS voltage in tilt-table testing for suspected neurally mediated syncope in a Chinese population.

Methods: This retrospective study enrolled patients with suspected neurally mediated syncope. Tilt-table testing was a part of the diagnostic examination. Each patient underwent echocardiography and electrocardiogram. isolated very low QRS voltage referred to a voltage of ⩽0.3 mV for the QRS complex in an isolated frontal lead or ⩽0.7 mV for the QRS complex in an isolated precordial lead.

Results: In total, 157 patients were included in the tilt-table testing positive group, and 242 patients were included in the tilt-table testing negative group. Compared with the testing negative group, the testing positive group had more patients with isolated very low QRS voltage in the frontal leads (p < 0.001). Moreover, for patients with isolated very low QRS voltage in the precordial leads, no significant difference was noted between the testing positive group and testing negative group (p = 0.289). Isolated very low QRS voltage in the frontal leads demonstrated 84.08% sensitivity and 74.38% specificity for a positive tilt-table testing response. The area under the curve of isolated very low QRS voltage for a positive tilt-table testing response in frontal leads was 0.806 (p < 0.0001).

Conclusion: In patients with suspected neurally mediated syncope, isolated very low QRS voltage in the frontal leads is a parameter that can predict a positive tilt-table testing response. The presence of isolated very low QRS voltage in frontal leads can serve as a parameter for evaluating syncope patients.

目的:晕厥的病因一般根据临床表现来确定。关于心电图在诊断神经介导性晕厥方面的价值,目前还鲜有讨论。本研究旨在测试倾斜台测试中孤立极低 QRS 电压对中国人群中疑似神经介导性晕厥的预测价值:这项回顾性研究招募了疑似神经介导性晕厥患者。倾斜台测试是诊断检查的一部分。孤立极低 QRS 电压是指孤立额前导联的 QRS 波群电压为 ⩽0.3 mV 或孤立心前导联的 QRS 波群电压为 ⩽0.7 mV:倾斜台测试阳性组共有 157 名患者,倾斜台测试阴性组共有 242 名患者。与倾斜台测试阴性组相比,倾斜台测试阳性组中额前导联出现孤立性极低 QRS 波群的患者更多(P = 0.289)。额导联孤立极低 QRS 电压对倾斜台测试阳性反应的敏感性为 84.08%,特异性为 74.38%。额导联孤立极低 QRS 电压对倾斜试验阳性反应的曲线下面积为 0.806(p 结论:额导联孤立极低 QRS 电压对倾斜试验阳性反应的敏感性和特异性分别为 84.08%和 74.38%:对于疑似神经介导的晕厥患者,额导联的孤立极低 QRS 电压是一个可以预测倾斜台测试阳性反应的参数。额导联出现孤立的极低 QRS 电压可作为评估晕厥患者的一个参数。
{"title":"Predictive value of isolated very low QRS voltage in tilt-table test for neurally mediated syncope.","authors":"Haichao Chen, Yiwei Cao, Lei Liang, Yan Gao, Jing Feng, Le Zhang, Lingxia Shi, Fengjun Chang, Gong Cheng, Haoyu Wu","doi":"10.1177/20503121241272661","DOIUrl":"https://doi.org/10.1177/20503121241272661","url":null,"abstract":"<p><strong>Objective: </strong>The cause of syncope is generally determined based on clinical manifestations. There has been little discussion about the value of electrocardiograms for diagnosing neurally mediated syncope. The aim of this study was to test the predictive value of the isolated very low QRS voltage in tilt-table testing for suspected neurally mediated syncope in a Chinese population.</p><p><strong>Methods: </strong>This retrospective study enrolled patients with suspected neurally mediated syncope. Tilt-table testing was a part of the diagnostic examination. Each patient underwent echocardiography and electrocardiogram. isolated very low QRS voltage referred to a voltage of ⩽0.3 mV for the QRS complex in an isolated frontal lead or ⩽0.7 mV for the QRS complex in an isolated precordial lead.</p><p><strong>Results: </strong>In total, 157 patients were included in the tilt-table testing positive group, and 242 patients were included in the tilt-table testing negative group. Compared with the testing negative group, the testing positive group had more patients with isolated very low QRS voltage in the frontal leads (<i>p</i> < 0.001). Moreover, for patients with isolated very low QRS voltage in the precordial leads, no significant difference was noted between the testing positive group and testing negative group (<i>p</i> = 0.289). Isolated very low QRS voltage in the frontal leads demonstrated 84.08% sensitivity and 74.38% specificity for a positive tilt-table testing response. The area under the curve of isolated very low QRS voltage for a positive tilt-table testing response in frontal leads was 0.806 (<i>p</i> < 0.0001).</p><p><strong>Conclusion: </strong>In patients with suspected neurally mediated syncope, isolated very low QRS voltage in the frontal leads is a parameter that can predict a positive tilt-table testing response. The presence of isolated very low QRS voltage in frontal leads can serve as a parameter for evaluating syncope patients.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241272661"},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D-QSAR, ADMET, and molecular docking studies of aztreonam analogs as E. colis inhibitors. 作为大肠杆菌抑制剂的阿兹曲南类似物的 3D-QSAR、ADMET 和分子对接研究。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241271810
Melese Legesse Mitku, Wudneh Simegn, Gashaw Sisay Chanie, Abdulwase Mohammed Seid, Alemante Tafese Beyna, Assefa Kebad Mengesha, Mihret Melese, Dereje Esubalew, Yibeltal Yismaw Gela, Wondim Ayenew, Liknaw Workie Limenh

Background: The development of multidrug resistant strains of extended-spectrum β-lactamase-producing Escherichia coli has become a global problem; therefore, the discovery of new antibacterial agents is the only available solution.

Objective: To improve and propose new compounds with antibacterial activity, the three-dimensional quantitative structure-activity relationship and molecular docking studies were carried out on Aztreonam analogs as E. coli inhibitors in DNA gyrase B.

Method: This study's 3D-Quantitative structure-activity relationship model was created using on the Comparative Molecular Field Analysis and the Comparative Molecular Similarity Indices Analysis. Using the Comparative Molecular Field Analysis (Q 2 = 0.73; R 2 = 0.82), excellent predictability was achieved, and the best Comparative Molecular Similarity Indices Analysis model (Q 2 = 0.88; R 2 = 0.9). The generated model's ability to predict outcomes was assessed through external validation using a test set compound and an applicability domain technique. In this study, the steric, electrostatic, and hydrogen bond acceptor fields played a key role in antibacterial activity.

Results: The results of the molecular docking revealed that the newly generated compound A6 has the highest binding affinity with DNA gyrase B. It forms 10 hydrogen bonds with amino acid residues of Asn104, Asn274, Asn132, Ser70, Ser237, Thr105, Glu273, and 2 salt bridges with amino acid residues of Ser70 and Glu273 and one pi-pi interacting with Gys271 amino acid residue in the binding site of 5G1, and this result was validated by a new assessment method. We created some novel, highly effective DNA gyrase B inhibitors based on the earlier findings, and the most accurate model predicted their inhibitory actions. The ADMET characteristics and pharmacological similarity of these novel inhibitors were also examined.

Conclusion: These findings would be very beneficial in guiding the optimization process for the identification of novel drugs that can address the issue of multiple drug resistance.

背景:产生广谱β-内酰胺酶的大肠埃希菌对多种药物产生耐药性已成为一个全球性问题,因此,发现新的抗菌剂是唯一可用的解决方案:为了改进并提出具有抗菌活性的新化合物,本研究对作为大肠杆菌 DNA 回旋酶 B 抑制剂的阿奇霉素类似物进行了三维定量构效关系和分子对接研究:本研究的三维定量结构-活性关系模型是利用比较分子场分析法和比较分子相似性指数分析法建立的。比较分子场分析法(Q 2 = 0.73;R 2 = 0.82)获得了极佳的预测能力,而比较分子相似性指数分析法模型(Q 2 = 0.88;R 2 = 0.9)则获得了最佳预测能力。通过使用测试集化合物和适用域技术进行外部验证,评估了生成的模型预测结果的能力。在这项研究中,立体场、静电场和氢键受体场在抗菌活性中发挥了关键作用:分子对接结果显示,新生成的化合物 A6 与 DNA gyrase B 的结合亲和力最高,它与 5G1 结合位点上的 Asn104、Asn274、Asn132、Ser70、Ser237、Thr105、Glu273 等氨基酸残基形成了 10 个氢键,与 Ser70 和 Glu273 等氨基酸残基形成了 2 个盐桥,与 Gys271 氨基酸残基形成了 1 个 pi-pi 作用,这一结果通过新的评估方法得到了验证。我们根据早先的发现创建了一些新型、高效的 DNA 回旋酶 B 抑制剂,最准确的模型预测了它们的抑制作用。我们还研究了这些新型抑制剂的 ADMET 特性和药理学相似性:这些发现将非常有助于指导优化过程,以确定能解决多重耐药性问题的新型药物。
{"title":"3D-QSAR, ADMET, and molecular docking studies of aztreonam analogs as <i>E. colis</i> inhibitors.","authors":"Melese Legesse Mitku, Wudneh Simegn, Gashaw Sisay Chanie, Abdulwase Mohammed Seid, Alemante Tafese Beyna, Assefa Kebad Mengesha, Mihret Melese, Dereje Esubalew, Yibeltal Yismaw Gela, Wondim Ayenew, Liknaw Workie Limenh","doi":"10.1177/20503121241271810","DOIUrl":"https://doi.org/10.1177/20503121241271810","url":null,"abstract":"<p><strong>Background: </strong>The development of multidrug resistant strains of extended-spectrum β-lactamase-producing <i>Escherichia coli</i> has become a global problem; therefore, the discovery of new antibacterial agents is the only available solution.</p><p><strong>Objective: </strong>To improve and propose new compounds with antibacterial activity, the three-dimensional quantitative structure-activity relationship and molecular docking studies were carried out on Aztreonam analogs as <i>E. coli</i> inhibitors in DNA gyrase B.</p><p><strong>Method: </strong>This study's 3D-Quantitative structure-activity relationship model was created using on the Comparative Molecular Field Analysis and the Comparative Molecular Similarity Indices Analysis. Using the Comparative Molecular Field Analysis (<i>Q</i> <sup>2</sup> = 0.73; <i>R</i> <sup>2</sup> = 0.82), excellent predictability was achieved, and the best Comparative Molecular Similarity Indices Analysis model (<i>Q</i> <sup>2</sup> = 0.88; <i>R</i> <sup>2</sup> = 0.9). The generated model's ability to predict outcomes was assessed through external validation using a test set compound and an applicability domain technique. In this study, the steric, electrostatic, and hydrogen bond acceptor fields played a key role in antibacterial activity.</p><p><strong>Results: </strong>The results of the molecular docking revealed that the newly generated compound A6 has the highest binding affinity with DNA gyrase B. It forms 10 hydrogen bonds with amino acid residues of Asn104, Asn274, Asn132, Ser70, Ser237, Thr105, Glu273, and 2 salt bridges with amino acid residues of Ser70 and Glu273 and one pi-pi interacting with Gys271 amino acid residue in the binding site of 5G1, and this result was validated by a new assessment method. We created some novel, highly effective DNA gyrase B inhibitors based on the earlier findings, and the most accurate model predicted their inhibitory actions. The ADMET characteristics and pharmacological similarity of these novel inhibitors were also examined.</p><p><strong>Conclusion: </strong>These findings would be very beneficial in guiding the optimization process for the identification of novel drugs that can address the issue of multiple drug resistance.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241271810"},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa: A retrospective cohort study in Jakarta, Indonesia. 感染肺炎克雷伯菌、鲍曼不动杆菌和铜绿假单胞菌的重症肺炎患者的抗生素耐药性相关因素和存活率分析:印度尼西亚雅加达的一项回顾性队列研究。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241264097
Gurmeet Singh, Tonny Loho, Mira Yulianti, Dita Aditianingsih, Laila Fakhriyatuz Zakiyah, Sudirman Fakhruddin Masse, Muhammad Rizki Triono

Background: Antimicrobial resistance is one of the most significant challenges to global public health and the risk factors in severe pneumonia are constantly growing. Therefore, this study aimed to identify factors associated with antimicrobial resistance and conduct survival analysis of severe pneumonia patients with single and multiple pathogens in the National Referral Hospital, Jakarta, Indonesia.

Methods: A retrospective method was used, and secondary data were collected from severe pneumonia patients admitted to the intensive care unit at Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia, from January 2016 to December 2022. Respiratory specimens were collected through bronchial washing. Furthermore, univariate and multivariate analyses were performed to analyze factors associated with antimicrobial resistance. Kaplan‒Meier survival curves were generated with the log-rank test to compare 30-day mortality between patients infected with single, dual, and multiple pathogens.

Results: The results showed that a total of 333 patients from 415 enrolled were analyzed. Klebsiella pneumoniae (35.4%), Acinetobacter baumannii (29.3%), and Pseudomonas aeruginosa (15.4%) were the most frequently isolated Gram-negative pathogens. Factors associated with resistance to aminoglycoside, carbapenem, and quinolone were sepsis, cerebrovascular disease, and ventilator-associated pneumonia, as indicated by p < 0.05. In addition, the Kaplan-Meier curves showed that multiple pathogens influenced the survival rate of severe pneumonia patients (p < 0.05).

Conclusions: Sepsis, cerebrovascular disease, and ventilator-associated pneumonia were associated with antimicrobial resistance in severe pneumonia patients. The survival rate of patients infected with multiple pathogens was low. This suggests the importance of further awareness regarding empirical antibiotic stewardship and mortality assessment in severe pneumonia patients.

背景:抗菌药耐药性是全球公共卫生面临的最大挑战之一,而重症肺炎的风险因素在不断增加。因此,本研究旨在确定与抗菌药耐药性相关的因素,并对印度尼西亚雅加达国立转诊医院的单病原体和多病原体重症肺炎患者进行生存分析:采用回顾性方法,从2016年1月至2022年12月印度尼西亚雅加达Cipto Mangunkusumo国立转诊医院重症监护室收治的重症肺炎患者中收集二手数据。呼吸道标本通过支气管冲洗采集。此外,还进行了单变量和多变量分析,以分析与抗菌药耐药性相关的因素。利用对数秩检验生成卡普兰-梅耶生存曲线,比较感染单一病原体、双重病原体和多重病原体患者的30天死亡率:结果显示,共对 415 名登记患者中的 333 名患者进行了分析。肺炎克雷伯菌(35.4%)、鲍曼不动杆菌(29.3%)和铜绿假单胞菌(15.4%)是最常见的革兰氏阴性病原体。对氨基糖苷类、碳青霉烯类和喹诺酮类药物产生耐药性的相关因素是败血症、脑血管疾病和呼吸机相关性肺炎:败血症、脑血管疾病和呼吸机相关肺炎与重症肺炎患者的抗菌药物耐药性有关。感染多种病原体的患者存活率较低。这表明,进一步提高对重症肺炎患者经验性抗生素管理和死亡率评估的认识非常重要。
{"title":"Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with <i>Klebsiella pneumoniae</i>, <i>Acinetobacter baumannii</i>, and <i>Pseudomonas aeruginosa</i>: A retrospective cohort study in Jakarta, Indonesia.","authors":"Gurmeet Singh, Tonny Loho, Mira Yulianti, Dita Aditianingsih, Laila Fakhriyatuz Zakiyah, Sudirman Fakhruddin Masse, Muhammad Rizki Triono","doi":"10.1177/20503121241264097","DOIUrl":"https://doi.org/10.1177/20503121241264097","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance is one of the most significant challenges to global public health and the risk factors in severe pneumonia are constantly growing. Therefore, this study aimed to identify factors associated with antimicrobial resistance and conduct survival analysis of severe pneumonia patients with single and multiple pathogens in the National Referral Hospital, Jakarta, Indonesia.</p><p><strong>Methods: </strong>A retrospective method was used, and secondary data were collected from severe pneumonia patients admitted to the intensive care unit at Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia, from January 2016 to December 2022. Respiratory specimens were collected through bronchial washing. Furthermore, univariate and multivariate analyses were performed to analyze factors associated with antimicrobial resistance. Kaplan‒Meier survival curves were generated with the log-rank test to compare 30-day mortality between patients infected with single, dual, and multiple pathogens.</p><p><strong>Results: </strong>The results showed that a total of 333 patients from 415 enrolled were analyzed. <i>Klebsiella pneumoniae</i> (35.4%), <i>Acinetobacter baumannii</i> (29.3<i>%</i>), and <i>Pseudomonas aeruginosa</i> (15.4%) were the most frequently isolated Gram-negative pathogens. Factors associated with resistance to aminoglycoside, carbapenem, and quinolone were sepsis, cerebrovascular disease, and ventilator-associated pneumonia, as indicated by <i>p</i> < 0.05. In addition, the Kaplan-Meier curves showed that multiple pathogens influenced the survival rate of severe pneumonia patients (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Sepsis, cerebrovascular disease, and ventilator-associated pneumonia were associated with antimicrobial resistance in severe pneumonia patients. The survival rate of patients infected with multiple pathogens was low. This suggests the importance of further awareness regarding empirical antibiotic stewardship and mortality assessment in severe pneumonia patients.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241264097"},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term results of nasolacrimal duct and inferior turbinate swing technique for inverted papilloma of the maxillary sinus. 鼻泪管和下鼻甲摆动技术治疗上颌窦倒置乳头状瘤的长期效果。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-20 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241271877
Yuji Nakamaru, Masanobu Suzuki, Ken Shizuki, Aya Honma, Akira Nakazono, Shogo Kimura, Ryosuke Watanabe, Satoshi Kano, Nayuta Tsushima, Takayoshi Suzuki, Akihiro Homma

Background: We developed a technique to preserve the entire nasolacrimal duct and inferior turbinate, by swinging the nasolacrimal duct upward and the inferior turbinate backward; that is, a nasolacrimal duct and inferior turbinate swing technique for sinonasal inverted papilloma of the maxillary sinus. In this study, we evaluated the long-term results of this technique.

Methods: A retrospective analysis was performed on the data for 53 consecutive pathologically confirmed inverted papilloma patients who were treated using nasolacrimal duct and inferior turbinate swing technique. The frequency of recurrence, the degree of nasolacrimal duct and inferior turbinate preservation, and the frequency of adverse events were assessed.

Results: The median follow-up period was 51 months (mean 62.5 months; range 10-187 months). No cases of recurrence within the maxillary sinus were observed among the cases treated using this technique, whereas three (5.7%) of the 53 cases experienced recurrence in areas other than the maxillary sinus. We could preserve the nasolacrimal duct in all cases. On the other hand, the inferior turbinate was resected during surgery in one case. No epiphora, dacryocystiits, numbness of the cheek, or collapse of the ala of the nose was observed.

Conclusion: This nasolacrimal duct and inferior turbinate swing technique method is a safe and effective method for the excision of primary or recurrent inverted papilloma and demonstrates low rates of recurrence and complications.

背景:我们开发了一种通过向上摆动鼻泪管和向后摆动下鼻甲来保留整个鼻泪管和下鼻甲的技术,即鼻泪管和下鼻甲摆动技术,用于治疗上颌窦倒置乳头状瘤。在本研究中,我们评估了该技术的长期效果:方法:我们对53例连续接受鼻泪管和下鼻甲摆动技术治疗的病理确诊倒置乳头状瘤患者的数据进行了回顾性分析。评估了复发频率、鼻泪管和下鼻甲的保留程度以及不良事件的发生频率:中位随访期为 51 个月(平均 62.5 个月;10-187 个月)。在使用该技术治疗的病例中,没有发现上颌窦内复发的病例,而在 53 例病例中,有 3 例(5.7%)在上颌窦以外的部位复发。我们在所有病例中都保留了鼻泪管。另一方面,有一个病例在手术中切除了下鼻甲。手术中未观察到衄血、泪囊肿、面颊麻木或鼻翼塌陷等情况:结论:这种鼻泪管和下鼻甲摆动技术方法是切除原发性或复发性倒置乳头状瘤的一种安全有效的方法,复发率和并发症发生率都很低。
{"title":"Long-term results of nasolacrimal duct and inferior turbinate swing technique for inverted papilloma of the maxillary sinus.","authors":"Yuji Nakamaru, Masanobu Suzuki, Ken Shizuki, Aya Honma, Akira Nakazono, Shogo Kimura, Ryosuke Watanabe, Satoshi Kano, Nayuta Tsushima, Takayoshi Suzuki, Akihiro Homma","doi":"10.1177/20503121241271877","DOIUrl":"10.1177/20503121241271877","url":null,"abstract":"<p><strong>Background: </strong>We developed a technique to preserve the entire nasolacrimal duct and inferior turbinate, by swinging the nasolacrimal duct upward and the inferior turbinate backward; that is, a nasolacrimal duct and inferior turbinate swing technique for sinonasal inverted papilloma of the maxillary sinus. In this study, we evaluated the long-term results of this technique.</p><p><strong>Methods: </strong>A retrospective analysis was performed on the data for 53 consecutive pathologically confirmed inverted papilloma patients who were treated using nasolacrimal duct and inferior turbinate swing technique. The frequency of recurrence, the degree of nasolacrimal duct and inferior turbinate preservation, and the frequency of adverse events were assessed.</p><p><strong>Results: </strong>The median follow-up period was 51 months (mean 62.5 months; range 10-187 months). No cases of recurrence within the maxillary sinus were observed among the cases treated using this technique, whereas three (5.7%) of the 53 cases experienced recurrence in areas other than the maxillary sinus. We could preserve the nasolacrimal duct in all cases. On the other hand, the inferior turbinate was resected during surgery in one case. No epiphora, dacryocystiits, numbness of the cheek, or collapse of the ala of the nose was observed.</p><p><strong>Conclusion: </strong>This nasolacrimal duct and inferior turbinate swing technique method is a safe and effective method for the excision of primary or recurrent inverted papilloma and demonstrates low rates of recurrence and complications.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241271877"},"PeriodicalIF":2.3,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment patterns and factors associated with discontinuation of monoclonal antibodies. 治疗模式以及与停用单克隆抗体相关的因素。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-19 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241271817
Muzoon Matar Saleh Alkaabi, Syed Arman Rabbani, Padma Gm Rao, Mai Ismail Mohamedelhassan

Background: Biological agents have revolutionized care in specialties such as oncology, immunology, infectious diseases, and genetic disorders, offering targeted actions on specific molecules or select immune cells. Monoclonal antibodies, known for their high specificity and precision, represent one of the most significant and rapidly expanding categories of these agents. Understanding the drug utilization patterns of monoclonal antibodies is crucial to ensure their optimal use, especially given their high cost and potential adverse effects.

Methods: This analytical cross-sectional study was conducted in a secondary hospital in the United Arab Emirates. Patients of either gender receiving monoclonal antibodies at the study site were included. Treatment patterns, utilization, and factors associated with the discontinuation of monoclonal antibodies were assessed.

Results: Hyperlipidemia (136, 39.1%) was the most common indication for monoclonal antibodies, followed by prophylaxis of respiratory syncytial virus infection in congenital heart disease (104, 29.9%) and osteoporosis (42, 12.1%). Evolocumab was the most commonly prescribed monoclonal antibody (135, 38.8%), followed by palivizumab (104, 29.9%), and dupilumab (38, 10.9%). The majority of monoclonal antibodies demonstrated a prescribed daily dose to defined daily dose ratio of 1.0, reflecting their appropriate utilization. One hundred twenty-nine patients (37.0%) discontinued their treatment during the study. Patient's level of education (OR: 0.416, 95% CI: 0.183-0.943, p = 0.036), BMI (OR: 2.358, 95% CI: 1.164-4.777, p = 0.017), number of concomitant medications (OR: 2.457, 95% CI: 1.202-5.025, p = 0.014), and treatment duration (OR: 9.180, 95% CI: 4.909-17.165, p < 0.001) were identified as predictors of discontinuation of monoclonal antibodies.

Conclusion: This study represents the first comprehensive investigation in the United Arab Emirates focused on treatment patterns, utilization, and discontinuation of monoclonal antibodies among the local population. Monoclonal antibodies were prescribed for the management of a wide range of clinical conditions. The study reports appropriate utilization of most monoclonal antibodies and identifies factors such as patient education level, BMI, concomitant medications, and treatment duration as independent predictors of monoclonal antibody treatment discontinuation.

背景:生物制剂为肿瘤学、免疫学、传染病和遗传性疾病等专科的治疗带来了革命性的变化,可对特定分子或选择性免疫细胞产生靶向作用。单克隆抗体以其高度特异性和精确性而著称,是生物制剂中最重要且发展迅速的一类。了解单克隆抗体的用药模式对确保其最佳使用至关重要,尤其是考虑到其高昂的成本和潜在的不良反应:这项横断面分析研究在阿拉伯联合酋长国的一家二级医院进行。研究对象包括在研究地点接受单克隆抗体治疗的男女患者。评估了治疗模式、使用情况以及与停用单克隆抗体相关的因素:高脂血症(136 例,39.1%)是单克隆抗体最常见的适应症,其次是先天性心脏病患者预防呼吸道合胞病毒感染(104 例,29.9%)和骨质疏松症(42 例,12.1%)。Evolocumab 是最常处方的单克隆抗体(135 例,38.8%),其次是 palivizumab(104 例,29.9%)和 dupilumab(38 例,10.9%)。大多数单克隆抗体的处方日剂量与定义日剂量之比为 1.0,反映了其使用的合理性。129名患者(37.0%)在研究期间中断了治疗。患者的受教育程度(OR:0.416,95% CI:0.183-0.943,p = 0.036)、体重指数(OR:2.358,95% CI:1.164-4.777,p = 0.017)、同时服用药物的数量(OR:2.457,95% CI:1.202-5.025,p = 0.014)和治疗持续时间(OR:9.180,95% CI:4.909-17.165,p 结论:本研究是阿拉伯联合酋长国首次对当地人群中单克隆抗体的治疗模式、使用和停药情况进行的全面调查。单克隆抗体被用于治疗多种临床疾病。研究报告指出了大多数单克隆抗体的合理使用情况,并确定了患者教育水平、体重指数、伴随药物和治疗持续时间等因素是预测单克隆抗体治疗中断的独立因素。
{"title":"Treatment patterns and factors associated with discontinuation of monoclonal antibodies.","authors":"Muzoon Matar Saleh Alkaabi, Syed Arman Rabbani, Padma Gm Rao, Mai Ismail Mohamedelhassan","doi":"10.1177/20503121241271817","DOIUrl":"10.1177/20503121241271817","url":null,"abstract":"<p><strong>Background: </strong>Biological agents have revolutionized care in specialties such as oncology, immunology, infectious diseases, and genetic disorders, offering targeted actions on specific molecules or select immune cells. Monoclonal antibodies, known for their high specificity and precision, represent one of the most significant and rapidly expanding categories of these agents. Understanding the drug utilization patterns of monoclonal antibodies is crucial to ensure their optimal use, especially given their high cost and potential adverse effects.</p><p><strong>Methods: </strong>This analytical cross-sectional study was conducted in a secondary hospital in the United Arab Emirates. Patients of either gender receiving monoclonal antibodies at the study site were included. Treatment patterns, utilization, and factors associated with the discontinuation of monoclonal antibodies were assessed.</p><p><strong>Results: </strong>Hyperlipidemia (136, 39.1%) was the most common indication for monoclonal antibodies, followed by prophylaxis of respiratory syncytial virus infection in congenital heart disease (104, 29.9%) and osteoporosis (42, 12.1%). Evolocumab was the most commonly prescribed monoclonal antibody (135, 38.8%), followed by palivizumab (104, 29.9%), and dupilumab (38, 10.9%). The majority of monoclonal antibodies demonstrated a prescribed daily dose to defined daily dose ratio of 1.0, reflecting their appropriate utilization. One hundred twenty-nine patients (37.0%) discontinued their treatment during the study. Patient's level of education (OR: 0.416, 95% CI: 0.183-0.943, <i>p</i> = 0.036), BMI (OR: 2.358, 95% CI: 1.164-4.777, <i>p</i> = 0.017), number of concomitant medications (OR: 2.457, 95% CI: 1.202-5.025, <i>p</i> = 0.014), and treatment duration (OR: 9.180, 95% CI: 4.909-17.165, p < 0.001) were identified as predictors of discontinuation of monoclonal antibodies.</p><p><strong>Conclusion: </strong>This study represents the first comprehensive investigation in the United Arab Emirates focused on treatment patterns, utilization, and discontinuation of monoclonal antibodies among the local population. Monoclonal antibodies were prescribed for the management of a wide range of clinical conditions. The study reports appropriate utilization of most monoclonal antibodies and identifies factors such as patient education level, BMI, concomitant medications, and treatment duration as independent predictors of monoclonal antibody treatment discontinuation.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241271817"},"PeriodicalIF":2.3,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
SAGE Open Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1